CSL Limited
CSL
Kedudukan dalam Saham
#368
CSL Limited operates as a global biopharmaceutical company, engaged in the... CSL Limited operates as a global biopharmaceutical company, engaged in the research, development, manufacturing, marketing, and distribution of diverse pharmaceutical and allied products. Its extensive international footprint includes key markets such as Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company is structured into two principal operating segments: CSL Behring and CSL Seqirus. CSL Behring focuses on plasma-derived therapies, encompassing both plasma products and recombinant treatments. This segment also conducts significant research into both plasma and non-plasma therapeutics and derives revenue from intellectual property licensing and royalties. In contrast, CSL Seqirus is dedicated to the manufacturing and worldwide distribution of non-plasma biotherapeutic products, alongside developing a range of influenza-related solutions. Founded in 1916, CSL Limited maintains its corporate headquarters in Parkville, Australia.
Harga Saham
$136.26
Modal Pasaran
$65.39B
Perubahan (1 hari)
-0.61%
Perubahan (1 tahun)
-4.06%
Negara
AU
Perdagangan CSL Limited (CSL)
Kategori
Healthcare
Sejarah dividen untuk CSL Limited (CSL)
CSL Limited (simbol saham: CSL) telah membuat sejumlah 64 pembayaran dividen.
Jumlah semua dividen (disesuaikan untuk pemecahan saham): $40.42
Hasil dividen (TTM): 0.0217
Jumlah semua dividen (disesuaikan untuk pemecahan saham): $40.42
Hasil dividen (TTM): 0.0217
Pembayaran dividen untuk CSL Limited (CSL) dari 1994 hingga 2026
Pembayaran dividen tahunan
| Tahun | Dividen (diselaraskan untuk pemecahan saham) | Ubah |
|---|---|---|
| 2026 (TTM) | $1.85 | -59.20% |
| 2025 | $4.52 | 13.84% |
| 2024 | $3.97 | 9.48% |
| 2023 | $3.63 | 14.09% |
| 2022 | $3.18 | 8.25% |
| 2021 | $2.94 | -0.07% |
| 2020 | $2.94 | 10.65% |
| 2019 | $2.66 | 16.41% |
| 2018 | $2.28 | 30.24% |
| 2017 | $1.75 | 3.04% |
| 2016 | $1.70 | 3.50% |
| 2015 | $1.64 | 32.85% |
| 2014 | $1.24 | 17.12% |
| 2013 | $1.06 | 27.28% |
| 2012 | $0.83 | 3.75% |
| 2011 | $0.8 | 0.00% |
| 2010 | $0.8 | 14.29% |
| 2009 | $0.7 | 52.17% |
| 2008 | $0.46 | 32.72% |
| 2007 | $0.3466 | 52.96% |
| 2006 | $0.2266 | 151.78% |
| 2005 | $0.09 | -28.97% |
| 2004 | $0.1267 | 11.83% |
| 2003 | $0.1133 | 0.00% |
| 2002 | $0.1133 | 30.68% |
| 2001 | $0.0867 | 13.04% |
| 2000 | $0.0767 | 9.57% |
| 1999 | $0.07 | 16.67% |
| 1998 | $0.06 | 16.28% |
| 1997 | $0.0516 | 18.89% |
| 1996 | $0.0434 | 8.50% |
| 1995 | $0.04 | 139.52% |
| 1994 | $0.0167 | 0.00% |
Senarai semua pembayaran dividen
| Tahun | Dividen | Ubah |
|---|---|---|
| 2026 (TTM) | $1.85 | -59.20% |
| 2025 | $4.52 | 13.84% |
| 2024 | $3.97 | 9.48% |
| 2023 | $3.63 | 15.74% |
| 2022 | $3.14 | 6.70% |
| 2021 | $2.94 | -0.07% |
| 2020 | $2.94 | 10.65% |
| 2019 | $2.66 | 16.41% |
| 2018 | $2.28 | 30.24% |
| 2017 | $1.75 | 3.04% |
| 2016 | $1.70 | 3.50% |
| 2015 | $1.64 | 32.85% |
| 2014 | $1.24 | 17.12% |
| 2013 | $1.06 | 27.28% |
| 2012 | $0.83 | 2.66% |
| 2011 | $0.8085 | -1.55% |
| 2010 | $0.8212 | 17.31% |
| 2009 | $0.7 | 52.17% |
| 2008 | $0.46 | -60.27% |
| 2007 | $1.16 | 70.28% |
| 2006 | $0.68 | 144.96% |
| 2005 | $0.2776 | -26.95% |
| 2004 | $0.38 | 11.76% |
| 2003 | $0.34 | 0.00% |
| 2002 | $0.34 | 30.77% |
| 2001 | $0.26 | 13.04% |
| 2000 | $0.23 | 9.52% |
| 1999 | $0.21 | 16.67% |
| 1998 | $0.18 | 16.13% |
| 1997 | $0.155 | 19.23% |
| 1996 | $0.13 | 8.33% |
| 1995 | $0.12 | 140.00% |
| 1994 | $0.05 | 0.00% |
Pembayaran dividen untuk syarikat serupa atau pesaing
| Syarikat | Jumlah pembayaran dividen | Negara |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
|
| 29.00% |
BE
|
